Alomone Labs社 TRPC1 and TRPC6: Driving Endotoxemic Cardiac Dysfunction
TRPC1 and TRPC6: Driving Endotoxemic Cardiac DysfunctionSepsis remains a critical healthcare issue that can lead to multiple organ failure, with heart complications being particularly deadly. New research published in Nature Communications explores how selectively 'switching off' TRPC1 and TRPC6 can prevent damaging inflammation and heart failure, paving the way for a potent new avenue of septic heart failure treatment.
|
|||||||||||||||||||||||||||
Why Alomone Labs? Because we've been producing and validating membrane protein molecular tools in-house for decades. |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。